These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32349021)

  • 21. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.
    Robinson CG; Patel AP; Bradley JD; DeWees T; Waqar SN; Morgensztern D; Baggstrom MQ; Govindan R; Bell JM; Guthrie TJ; Colditz GA; Crabtree TD; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
    J Clin Oncol; 2015 Mar; 33(8):870-6. PubMed ID: 25667283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
    J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
    Yang CF; Meyerhoff RR; Mayne NR; Singhapricha T; Toomey CB; Speicher PJ; Hartwig MG; Tong BC; Onaitis MW; Harpole DH; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1615-23. PubMed ID: 26719408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical outcomes for non-small cell lung cancer in younger adults: A population-based study.
    Zhang Z; Huo H; Li F; Miao J; Hu B; Chen S
    Thorac Cancer; 2024 May; 15(15):1218-1227. PubMed ID: 38606839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
    Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
    Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features.
    Pathak R; Goldberg SB; Canavan M; Herrin J; Hoag JR; Salazar MC; Papageorge M; Ermer T; Boffa DJ
    JAMA Oncol; 2020 Nov; 6(11):1741-1750. PubMed ID: 32940636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and Predictors of Chemotherapy Use for Resected Non-Small Cell Lung Cancer.
    Rajaram R; Paruch JL; Mohanty S; Holl JL; Bilimoria KY; Ko CY; Winchester DP; Patel JD; DeCamp MM
    Ann Thorac Surg; 2016 Feb; 101(2):533-40. PubMed ID: 26507427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer.
    Wu F; Lu M; Qu L; Li DQ; Hu CH
    Int J Clin Exp Pathol; 2015; 8(5):5457-63. PubMed ID: 26191250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real life adjuvant chemotherapy uptake and survival in patients with non-small cell lung cancer after complete resection.
    Kolek V; Losse S; Kultan J; Jakubec P; Jaromir Z; Sova M; Szkorupa M; Neoral Č; Škarda J; Tichý T; Kolář Z
    Curr Med Res Opin; 2018 Sep; 34(9):1687-1694. PubMed ID: 29912578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.
    Ahmad U; Crabtree TD; Patel AP; Morgensztern D; Robinson CG; Krupnick AS; Kreisel D; Jones DR; Patterson GA; Meyers BF; Puri V
    Ann Thorac Surg; 2017 Jul; 104(1):303-307. PubMed ID: 28433225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer.
    Williams CD; Gajra A; Ganti AK; Kelley MJ
    Cancer; 2014 Jul; 120(13):1939-47. PubMed ID: 24668613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
    Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    Zheng D; Ye T; Hu H; Zhang Y; Sun Y; Xiang J; Chen H
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1814-1822.e4. PubMed ID: 29221745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer.
    Park TS; Kim HR; Koh JS; Jang SH; Hwang YI; Yoon HI; Chung JH; Kim CH; Kim SS; Kim WS; Jo J; Lee JC; Choi CM
    Lung Cancer; 2014 Nov; 86(2):262-7. PubMed ID: 25261232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.